GLAST+ and Proteoglycan‐4+ (PRG4+) EVs were elevated in ALS patients, with PRG4+ EVs particularly enriched in those with preserved cognitive function. This evidence concerns the gene PRG4 and amyotrophic lateral sclerosis.